John C.k. Milligan IV, President/Secretary at TherapeuticsMD, Inc. (TXMD), bought 15,000 shares at $3.16 ($47K) on 2019-08-12, disclosed to the SEC on 2019-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2019-08-19 | $29K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |
| TXMD | SELL | 2018-12-06 | $1.2M | — | Filing → |